
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
MEDIPOST is founded in 2000, and today MEDIPOST is leading the global stem cell therapeutics field with the worlds first regulatory-approved allogeneic human Umbilical Cord Blood-derived Mesenchymal Stem Cell(hUCB-MSC) product named CARTISTEM for patients with knee Osteoarthritis(OA), launched in Korean market in 2012. MEDIPOST operates the largest private cord blood bank CELLTREE in Korea with over 255,000 units of private cord blood units under storage. Each year, over 20,000 private cord blood units are collected and stored at CELLTREE. MEDIPOSTs research and development is focused on novel off-the-shelf, allogeneic cell therapeutics using human Umbilical Cord Blood-derived Mesenchymal Stromal Cells (hUCB-MSCs)...
줄기세포치료제,제대혈보관,and 건강기능식품
Medipost (subsidiary company_evastem) operates in the Biotechnology research industry.
Medipost (subsidiary company_evastem)'s revenue is 11m - 100m
Medipost (subsidiary company_evastem) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.